PHARMACYTE BIOTECH, INC. Lessee, Operating Lease, Liability, to be Paid
PHARMACYTE BIOTECH, INC. (PMCB) had Lessee, Operating Lease, Liability, to be Paid of $1.16 thousand as of 2023-01-31, per its 10-Q filed 2023-03-16.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2023-03-16
- 2023-01-31: Lessee, Operating Lease, Liability, to be Paid $1.16K.
- 2022-10-31: Lessee, Operating Lease, Liability, to be Paid $2.32K.
- 2022-07-31: Lessee, Operating Lease, Liability, to be Paid $3.34K.
- 2022-04-30: Lessee, Operating Lease, Liability, to be Paid $2.05K.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2023-01-31 | $1.16K 10-Q · filed 2023-03-16 |
| 2022-10-31 | $2.32K 10-Q · filed 2022-12-14 |
| 2022-07-31 | $3.34K 10-Q · filed 2022-09-14 |
| 2022-04-30 | $2.05K 10-K · filed 2022-07-28 |
| 2022-01-31 | $4.25K 10-Q · filed 2022-03-15 |
| 2021-10-31 | $6.88K 10-Q · filed 2021-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |